OVERVIEW

Nuanced Belatacept Dosing is organized by University of Illinois at Chicago (UIC) College of Pharmacy.

Release Date: October 24, 2024
Expiration Date: October 24, 2026

Learning Objectives:

  • Review key components of strategies for conversion to belatacept that are safe and effective
  • Select an appropriate candidate for alternative belatacept dosing, and design a safe alternative dosing regimen
  • Examine belatacept regimens which reduce immunosuppression and mitigate infection
Credits

Continuing Education Statement:
The UIC Retzky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. The non-accredited cosponsor for this activity is the Illinois Transplant Pharmacists Association. This activity has been assigned an ACPE Universal Activity, for 0.75 contact hours (0.075 CEUs). Reading the learning objectives and faculty disclosures; participating in the entire knowledge-based activity, active learning activity, post-test, and activity evaluation; estimating the duration of time spent on the activity; and submitting NABP eProfile ID and MMDD are prerequisites for receiving continuing pharmacy education credits. All ACPE credit awarded to participants must be uploaded to CPE Monitor ™ within 30 days of the activity date, so pharmacists are required to provide their eProfile ID and date of birth (MMDD) at the time of the activity. 

  • 0.75 Contact Hours
  • 0.075 CEUs
  • TARGET AUDIENCE

    Pharmacist

    SPECIALITIES

    Immunology and Microbiology

    RELATED ONLINE COURSES